(2S)-(+)-2-溴-1-(6'-甲氧基-2'-萘基)丙-1-酮的不对称合成

以(2R,3R)-酒石酸二甲酯为手性辅助剂,6-甲氧基-2-丙酰基萘经缩酮化、溴化铜不对称溴化、水解等反应合成了(2S)-2-溴-1-(6'-甲氧基-2'-萘基)丙-1-酮。总收率94%。     

由2',4'-二氢-6'-甲氧基-3',5'-二甲基查耳酮合成新黄酮

在DMSO/ I2的氧化作用下,由2',4'-二氢-6'-甲氧基-3',5'-二甲基查耳酮可合成一种全新结构的黄酮:7-羟基-5-甲氧基-6,8-二甲基黄酮(产率91%),而在HCl/MeOH作用下则得到了两种黄烷酮:7-羟基-5-甲氧基-6,8-二甲基黄烷酮 (产率70%) 和 5,7-二羟基-6,8-二甲基黄烷酮 (产率20%).     

4,6-二氯-5-(2-甲氧基苯氧基)-2,2'-联嘧啶的合成

以丙二酸二乙酯为原料,经溴化、醚化得甲氧基苯氧基丙二酸二乙酯(3);3与嘧啶甲脒环合、卤代合成了4,6-二氯-5-(2-甲氧基-苯氧基)-2,2'-联嘧啶,总收率37.29%,其结构经1H NMR,IR和MS确证。     

聚[(S)-3-乙烯基-2,2'-二羟基-1,1'-联萘]的钛配合物催化三乙基铝对醛的不对称加成反应

通过维蒂希反应合成了(S)-3-乙烯基-2,2'-甲氧甲氧基-1,1'-联萘.将单体(S)-3-乙烯基-2,2'-甲氧甲氧基-1,1'-联萘用偶氮二异丁腈作引发剂进行自由基聚合得到了聚[(S)-3-乙烯基-2,2'-二甲氧基甲氧基-1,1'-联萘].该聚合物上的MOM保护基通过酸脱除获得手性螺旋聚合物聚[(S)-3-乙烯基-2,2'-二羟基-1,1'-联萘].将手性螺旋聚合物聚[(S)-3-乙烯基-2,2'-二羟基-1,1'-联萘]与Ti(O-i-Pr)4形成的配合物应用于三乙基铝与醛的不对称加成反应中,获得了较好的对映选择性,ee值最高为85%.更重要的是,这种聚合物还可以被回收利用多次且催化活性没有明显降低.     

2-溴-4,4'-二硝基-3'-二甲基锍-2'-联苯酚内盐的合成、结构及性质的研究

在胺存在下,3,7-二硝基二苯并溴五环硫酸氢盐与二甲基亚砜反应生成2-溴-4,4'-二硝基-3'-二甲基锍-2'-联苯酚内盐(3).3的X射线晶体结构分析数据表明其分子具有内盐结构但酚氧负离子的负电荷是部分离域的,分子内两苯环所成的两面角为117.3°.3在熔解时发生重排及热分解分别生成2-溴-2'-甲氧基-3'-甲硫基-4,4'-二硝基联苯(6)及3,7-二硝基-4-甲硫基-二苯并呋喃(7).3与盐酸反应生成相应的锍盐(8).     

5,8,5'''',8''''-二甲氧基-3,3''''-二亚甲基-2,2''''-双喹啉的合成

2-氨基-3,6-二甲氧基苯甲醛与1,2-环己二酮发生Friedlander缩合反应合成了新化合物5,8,5',8'-二甲氧基-3,3'-二亚甲基-2,2'-双喹啉,其结构经UV,1H NMR,IR和MS表征.     

铑/(2S,2'S,3S,3'S)-3,3'-二叔丁基-4,4'-二甲氧基-2,2',3,3'-四氢-2,2'-联苯并[d][1,3]草酰膦(MeO-BIBOP)催化的不对称还原烯胺合成(R)-3-叔丁氧羰基氨基-4-(2,4,5-三氟苯基)丁酸

(R)-3-氨基-4-(2,4,5-三氟苯基)丁酸是重要的药物中间体,因此发展其高立体选择性的合成方法极具有实用价值.通过实验研究发现[Rh(NBD)2]+BF4-/(2S,2'S,3S,3'S)-3,3'-二叔丁基-4,4'-二甲氧基-2,2',3,3'-四氢-2,2'-联苯并[d][1,3]草酰膦(MeO-BIBO...     

4,4''''-二甲氧基-5,6,5'''',6''''-二次甲二氧基-2-烷氧甲酰基-2''''-(4-取代苄基哌嗪基-1)-甲酰基联苯的合成

在NiCl2(PPh3)2/NaH/Zn/PPh3作用下,以2-溴-3,4-次甲二氧基-5-甲氧基-苯甲酸甲酯为原料进行Ullmann-type偶合,在温和条件下以较高的收率得到中间体4,4'-二甲氧基-5,6,5',6'-二次甲二氧基联苯-2,2'-二甲酸二甲酯,经进一步的水解、环化成酸酐、开环酯化等反应得到4,4'-二甲氧基-5,6,5',6'-二次甲二氧基联苯-2,2'-二甲酸单酯.最后再与取代苄基哌嗪在DMAP及DCC催化下缩合,得到12个新的不对称联苯甲酸酯甲酰哌嗪类化合物,并用1H NMR,IR,ESI-MS等手段进行了结构确认.     

6,6'-取代1,1'-联二萘酚衍生的手性磷酸的合成

1,1'-联二萘酚(1)经溴代反应制得6,6'-二溴-1,1'-联二萘酚(2);2经苄基保护羟基制得2,2'-二苄氧基-6,6'-二溴-1,1'-联二萘(3);3经Ullmann缩合在6,6'-位引入甲氧基制得2,2'-二苄氧基-6,6'-二甲氧基-1,1'-联二萘(4b);3经Kumada偶联反应在6,6'-位引入正己基制得2,2'-二苄氧基-6,6'-二正己基-1,1'-联二萘(4c);4b和4c经还原脱去苄基制得6,6'-位取代1,1'-联二萘酚(5b和5c);2,5b和5c分别与三氯氧磷反应合成了3种1的6,6'-位取代手性磷酸(6a~6c),其结构经1H NMR和31P NMR表征。其中6c为新化合物。     

2-芳胺基-5-[5'-氨基-1'-(4"-氯苯基)-1',2',3'-三唑-4'-基]-1,3,4-噻二唑的合成

1-[5'-氨基-1'-(4"-氯苯基)-1,2,3-三唑-4'-甲酰基]-4-芳基-3-氨基硫脲在浓硫酸催化下环化得到2-芳胺基-5-[5'-氨基-1'-(4"-氯苯基)-1',2',3',-三唑-4'-基]-1,3,4-噻二唑2a-i, 依此法合成了九个标题化合物, 收率为30-74%。化合物2i的结构用X-光衍射单晶分析确证。     

Novel Copolymers of Styrene. 6. Some Oxy Ring-Disubstituted Butyl 2-Cyano-3-Phenyl-2-Propenoates

Novel trisubstituted ethylenes, oxy ring-disubstituted butyl 2-cyano-3-phenyl-2-propenoates, RPhCH=C(CN)CO₂C₄H₉ (where R is 4-methoxy-2-methyl, 4-methoxy-3-methyl, 3-ethoxy-4-methoxy, 4-ethoxy-3-methoxy, 3,4-dibenzyloxy, 2-benzyloxy-3-methoxy, and 3-benzyloxy-4-methoxy) were prepared and copolymerized with styrene. The monomers were synthesized by the piperidine catalyzed Knoevenagel condensation of ring-substituted benzaldehydes and butyl cyanoacetate, and characterized by CHN analysis, IR, ¹H and ¹³C-NMR. All the ethylenes were copolymerized with styrene (M₁) in solution with radical initiation (ABCN) at 70°C. The compositions of the copolymers were calculated from nitrogen analysis and the structures were analyzed by IR, ¹H and ¹³C-NMR.

Decomposition of the copolymers in nitrogen occurred in two steps, first in the 200-500°C range with residue (2-17 % wt.), which then decomposed in the 500-800°C range.     

Novel copolymers of styrene. 6. Some oxy ring-disubstituted propyl 2-cyano-3-phenyl-2-propenoates

Novel trisubstituted ethylenes, oxy ring-disubstituted propyl 2-cyano-3-phenyl-2-propenoates, RPhCH = C(CN)CO₂C₃H₇ (where R is 4-methoxy-2-methyl, 4-methoxy-3-methyl, 3-ethoxy-4-methoxy, 3,4-dibenzyloxy, 3-benzyloxy-4-methoxy, 4-benzyloxy-3-methoxy) were prepared and copolymerized with styrene. The monomers were synthesized by the piperidine catalyzed Knoevenagel condensation of ring-substituted benzaldehydes and propyl cyanoacetate and characterized by CHN elemental analysis, IR, ¹H- and ¹³C-NMR. All the ethylenes were copolymerized with styrene (M₁) in solution with radical initiation (ABCN) at 70°C. The composition of the copolymers was calculated from nitrogen analysis, and the structures were analyzed by IR, ¹H and ¹³C-NMR, GPC, DSC, and TGA. Decomposition of the copolymers in nitrogen occurred in two steps, first in the 200–500°C range with residue (3–22% wt.), which then decomposed in the 500–800°C range.     

Cyclization of 2-methoxy-6-(substituted benzyloxy)acetophenone hydrazones in the presence of polyphosphoric acid(PPA)

Cyclization of 2-methoxy-6-benzyloxy acetophenone hydrazone gave 3-methyl-4-meth-oxy indazole and 3-methyl-4-methoxy-7-benzyl indazole in the presence of polyphosphoric acid(PPA).The hydrazone was probably converted to 2-hydroxy-6-methoxy acetophenone hydra-zone and 2-hydroxy-3-benzyl-6-methoxy acetophenone hydrazone followed by cyclization to thecorresponding indazoles in acidic conditions.Cyelization of 2-methoxy-6-(halo or alkyl or arylbenzyloxy)acetophenone hydrazones gave similar products.Cyclization of 2-methoxy-6-(p-nitrobenzyloxy)acetophenone hydrazone gave 2-(p-nitrophenyl)-3-methyl-4-methoxy benzo-furan and 3-methyl-4-methoxy indazole while 2-methoxy-6-(m-nitrobenzyloxy)acetophenonehydrazone gave 3-methyl-4-methoxy indazole,3-methyl-4-methoxy-7-(m-nitrophenyl)indazole and3-methyl-4-(m-nitrobenzyloxy)indazole.     

Syntheses of the enantiomers of 1-deoxynojirimycin and 1-deoxyaltronojirimycin via chemo- and diastereoselective olefinic oxidation of unsaturated amines

Oxidation of enantiomerically pure (R)-N(1)-1'-(1'-naphthyl)ethyl-2,7-dihydro-1H-azepine with m-CPBA in the presence of HBF(4) and BnOH gave (3S,4R,5S,6S,1'R)-N(1)-1'-(1'-naphthyl)ethyl-3-hydroxy-4-benzyloxy-5,6-epoxyazepane as the major product and as a single diastereoisomer after chromatography. Elaboration of this highly functionalized intermediate via ring contraction to (2S,3R,4S,5S,1'R)-N(1)-benzyl-2-chloromethyl-3-benzyloxy-4,5-epoxypiperidine followed by regioselective epoxide ring opening, functional group manipulation, and deprotection gave (+)-1-deoxyaltronojirimycin. Alternatively, resolution of (RS,RS)-N(1)-benzyl-3-hydroxy-4-benzyloxy-2,3,4,7-tetrahydro-1H-azepine or (3RS,4SR,5RS,6RS)-N(1)-benzyl-3-hydroxy-4-benzyloxy-5,6-epoxyazepane by preparative chiral HPLC and subsequent elaboration allows access to the enantiomers of 1-deoxynojirimycin and 1-deoxyaltronojirimycin, respectively.     

若干D环带硝基的小檗因衍生物的光环化合成

通过酰烯胺的光环化反应, 合成了六个D环带硝基的小檗因类化合物。在酰烯胺的制备中, 还得到了几个非预期的副产物, 阐明了它们的结构。     

Studies on the Constituents of Formosan Salvia Plebeia R. Br. (I) On the Flavonoid Components of Salvia Plebeia R. Br.

Salvia plebeia R. Br. is an annual herb of Labiatae and is widely distributed in the central area of Taiwan. It has been used as folk-medicine for the treatment of hepatitis and tumors.¹⁾ From the flavonoid enriched fraction (B) of the alcoholic extracts of this plant, four kinds of flavonoid compound were isolated. Two of these were confirmed as 5,4′-dihydroxy-6-methoxy-7-glucosyloxy flavone (I). (homoplantaginin, hispidulin-7-glucoside) and 5, 7, 4′-trihydroxy-6-methoxy flavone (II) (hispidulin) on the basis of their spectral, chemical evidences and comparison with authentic samples. The other two were assigned to be 5, 3′, 4′-trihydroxy-6-methoxy-7-glucosyloxy flavone (III) (nepitrin, eupafolin-7-glucoside) and 5,7,3′,4′-tetrahydroxy-6-methoxy flavone (IV) (eupafolin, nepetin) on the basis of chemical and spectral properties. The flavones, II (hispidulin) and IV (eupafolin), have been shown to have cytotoxic activity against human carcinoma of the nasopharynx carried in cell culture (KB).¹³⁾     

Preparation of perhydroisoquinolines via the intramolecular Diels-Alder reaction of N-3,5-hexadienoyl ethyl acrylimidates: a formal synthesis of (+/-)-reserpine

The intramolecular Diels-Alder reaction of N-3,5-hexadienoyl ethyl acrylimidates provides an efficient method for the synthesis of cis-fused hexahydroisoquinolones. As a demonstration of the stereochemical control offered by this cycloaddition, two approaches to the construction of the DE rings of reserpine are reported. In the second entry, N-((4-(trimethylsilyl)ethoxymethoxy)methyl-6-benzyloxy-3Z,5E-hexadienoyl)-1-aza-2-ethoxy-1,3-butadiene (40) undergoes cycloaddition to produce as the major product (4aS,7R,8aS)-7-benzyloxy-5-((2-trimethylsilyl)ethoxymethoxy)methyl-3,4,4a,7,8,8a-hexahydroisoquinol-3-one (41). Cycloadduct 41 is then stereospecifically elaborated to (4aS,5S,6R,7R,8aR)-6-methoxy-5-methoxycarbonyl-7-(3,4,5-trimethoxy)benzoyldecahydroisoquinoline-2-carboxylic acid methyl ester (3), a key intermediate previously transformed to reserpine.     

Synthesis,cytotoxic, and carbonic anhydrase inhibitory effects of new 2-(3-(4-methoxyphenyl)-5-(aryl)-4,5-dihydro-1H-pyrazol-1-yl)benzo[d]thiazole derivatives

2-(3-[4-Methoxyphenyl]-5-aryl-4,5-dihydro-1H-pyrazol-1-yl)benzo[d]thiazoles ( 1b-7b ) were synthesized for the first time except 1b , and spectral methods such as ¹H NMR, ¹³C NMR and HRMS were utilized to illuminate the chemical structures of the synthesized compounds. Phenyl ( 1b ), 2-methoxyphenyl ( 2b ), 4-methoxyphenyl ( 3b ), 4-methoxy-3-hydroxyphenyl ( 4b ), 2,5-dimethoxyphenyl ( 5b ), 3,4,5-trimethoxyphenyl ( 6b ), or thiophene-2-yl ( 7b ) was used as a aryl part. The inhibitory effects of the compounds were evaluated toward human carbonic anhydrase I and II enzymes (hCA I and hCA II). In vitro cytotoxic effects of the compounds against human oral squamous carcinomas and human normal oral cells were carried out via MTT. The compounds ( 1b-7b ) had Ki values of 36.87 ± 11.62-66.24 ± 2.99 μM (hCA I) and 22.66 ± 1.41-89.95 ± 6.25 μM (hCA II). Compounds 1b (Ki = 36.87 ± 11.62 μM) toward hCA I, 6b (Ki = 22.66 ± 1.41 μM) toward hCA II had significant enzyme inhibitory potency. Compound 6b had the highest tumor selectivity (TS = 29.3) and potency selectivity expression (PSE = 272.3) values. Therefore, compounds 1b and 6b with CAs inhibition effect and compound 6b with the cytotoxicity may be forwarded to further studies as potent compounds.     

The tautomerism of Omeprazole in solution: a 1H and 13C NMR study

The tautomerism of 5(6)-methoxy-2-([(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl] sulfinyl)-1H-benzimidazole (omeprazole) was determined in solution, K(T) = 0.59 in THF at 195 K, in favor of the 6-methoxy tautomer. The assignment of the signals was made by comparison with its two N-methyl derivatives in acetone-d6 and through theoretical calculations of the absolute shieldings (GIAO/DFT/6-311++G**).     

Stereocontrolled transformation of nitrohexofuranoses into cyclopentylamines via 2-oxabicyclo[2.2.1]heptanes. Part 6: synthesis and incorporation into peptides of the first reported 2,3-dihydroxycyclopentanecarboxylic acid

Herein we report the intramolecular alkylation of nitronates of methyl-5-O-benzyl-3,6-deoxy-6-nitro-β-d-glucofuranoside and methyl-5-O-benzyl-3,6-deoxy-6-nitro-α-d-glucofuranoside into the corresponding 2-oxabicyclo[2.2.1]heptane derivatives. Similarly, methyl-3-O-benzyl-5-deoxy-5-nitromethyl-β-d-xylofuranoside and methyl-3-O-benzyl-5-deoxy-5-nitromethyl-α-d-xylofuranoside were cyclized to (1R,3R,4S,5R,7R)-7-benzyloxy-3-methoxy-5-nitro-2-oxabicyclo[2.2.1]heptane and (1R,3S,4S,5R,7R)-7-benzyloxy-3-methoxy-5-nitro-2-oxabicyclo[2.2.1]heptane, respectively. These 2-oxabicyclo[2.2.1]heptane derivatives were eventually transformed into enantiopure methyl (1S,2S,3R,4S,5R)-2-amino-2,3-dihydroxycyclopentanecarboxylate and this novel β-amino acid was incorporated into peptides.